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Anticancer Drug Camptothecin Test 
in 3D Hydrogel Networks with HeLa 
cells
Jun Liang1,2, Xiuzhi Susan Sun2,3, Zhilong Yang4 & Shuai Cao4
Development of a biomimetic 3D culture system for drug screening is necessary to fully understand 
the in vivo environment. Previously, a self-assembling peptide hydrogel has been reported; the 
hydrogel exhibited physiological properties superior to a 3D cell culture matrix. In this work, further 
research using H9e hydrogel with HeLa cells was carried out considering H9e hydrogel’s interaction 
with camptothecin, a hydrophobic drug. According to AFM images, a PGworks solution triggered 
H9e hydrogel fiber aggregation and forms a 3D matrix suitable for cell culture. Dynamic rheological 
studies showed that camptothecin was encapsulated within the hydrogel network concurrently with 
peptide self-assembly without permanently destroying the hydrogel’s architecture and remodeling 
ability. Fluorescence measurement indicated negligible interaction between the fluorophore part of 
camptothecin and the hydrogel, especially at concentration 0.25 and 0.5 wt%. Using a dialysis method, 
we found that H9e hydrogel could not significantly inhibit the diffusion of camptothecin encapsulated 
inside the hydrogel matrix. In the cell culture experiment, HeLa cells were simultaneously embedded 
in the H9e hydrogel with the initialization of hydrogelation. Most importantly, cell viability data after 
camptothecin treatment showed responses that were drug-dose dependent but unaffected by the H9e 
hydrogel concentration, indicating that the hydrogel did not inhibit the drug.
The use of the cell-based model is still the main method for in vitro drug efficacy screening to more expediently 
determine optimal drug dosage in cancer therapy. The traditional two-dimensional (2D) cell based model has 
been limited by its low prediction efficiency compared to animal models, because of lack of multiple physical 
(e.g. stiffness, porosity and stress/strain), chemical cues (e.g. morphogens) and micoenvironmental elements 
(e.g. supporting extracellular matrix) resulting in various physiological performance issues1–7. Hence scientists 
and industries are switching to three-dimensional (3D) cell based models that are more accurately mimicking the 
native extracellular matrix (ECM) for in vitro cell culture8,9. Several matrix systems have been available for 3D cell 
cultures including PEG-fibrin hydrogel10, hyaluronic acid11, low-viscocity bioink12, fibrinogen and polyethylene 
Glycol13, etc., and among those, peptide hydrogel system becomes attractive due to its high water contents, good 
biocompatibility and using convenience.
The novel PepGel (H9e) peptide have been invented and serials of work have been done to explore its poten-
tial usage14,15. The peptide can form a solid physical hydrogel through in vitro assembly under conditions that 
mimic physiological conditions (i.e., neutral pH, 37 °C). Physical gelation under physiological conditions allows 
3D homogeneous cell encapsulation. Moreover, h9e hydrogel displays shear-thinning and repeatedly reversible 
sol-gel transfer properties that enable pipette transfer of cell cultures14.
Drug diffusion in the 3D hydrogel network is an important factor in drug efficacy screening tests16. Some 
peptide hydrogels possess very strong adhesion to small molecules, making them potential carriers for controlled 
release17,18; however, for drug efficacy tests in 3D cell cultures, strong affinity between drugs and matrices can 
have negative effects. The matrix must have suitable diffusion properties in order to give the tested drug sufficient 
access to cells, and strong binding of drug molecules onto the hydrogel matrix could inhibit drug diffusion and 
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reduce the drugs’ effects, creating inaccurate experimental results17. Thus, the interaction between H9e peptide 
and drugs must be studied, to ensure h9e hydrogel does not inhibit the effect of drug19.
In this research, we examined the suitability of the peptide hydrogel as a 3D system to evaluate the efficacy of 
small hydrophobic anticancer drug molecules. We selected camptothecin as the drug molecule because it exhib-
ited remarkable anticancer activity in preliminary clinical trials but low solubility in aqueous solution19–22. We 
focused on the interaction of h9e hydrogel nanofibers and the selected drug along with drug diffusion in the 
3D system. An luminescence method was used to detect the interaction between camptothecin and h9e hydro-
gel, atomic force microscopy (AFM) was used to image the hydrogel formation, and a rheometer was used to 
study the drug’s influence on hydrogel strength and sol-gel recovery properties. UV-absorbance was performed 
to detect the diffusion of camptothecin as a function of hydrogel concentration. HeLa cells were used as a model 
to test the performance of camptothecin in various concentrations of the h9e hydrogel. A combination of physical 
and biological analysis proved that h9e hydrogel was a potential promising 3D cell culture for hydrophobic drug 
camptothecin.
Results and Discussion
Camptothecin interaction with h9e hydrogel. Camptothecin is a naturally fluorescent molecule. The 
fluorescence spectrum, a measure of the average energy of emission, is related to the polarity and flexibility of the 
polyphenolic side-chain environment23. Permana and his coworkers reported that the interaction of camptothe-
cin with carbon nanotubes generated an over- 20 nm shift at most in the fluorescence peak from camptothecin24. 
In this study, we used fluorescence spectroscopy to study microenvironment changes of camptothecin in H9e 
hydrogel. Figure 1 overlays normalized fluorescence bands of 2.5 mM camptothecin in 0.25, 0.5, and 1% of h9e 
hydrogel and the control sample of 25 μ M camptothecin in 100 mM sodium bicarbonate solution. As shown in 
the insert of Fig. 1, an introduce of 1% h9e hydrogel only leads to a 3-nm shift in the peak of fluorescence from 
camptothecin, indicating that the interaction between camptothecin and h9e peptide fibers is minor.
Atomic force microscopy(AFM). Peptide hydrogel can be formed by adjusting pH25, temperature26, or 
chemical cross-linkers27, depending on the peptide backbone structure. Specific protein-peptide interactions have 
been used to direct self-assembly of peptide nanowires into micrometer-sized crystalline cubes28. For gelation 
in this study, h9e hydrogel was triggered by PGworks solution with bovine serum albumin (BSA) as the main 
functional component. AFM showed that the peptide can self-assemble into nanofibers with a lot of fragments, 
even without the PGwork trigger solution (Fig. 2A); however, these nanofibers did not form stable 3D networks 
as hydrogel, most likely due to the lack of strong interactions between peptides at this concentration. After the 
addition of PGworks solution, the fragments disappeared and longer fibers were observed, forming extensive 
cross-linking points, leading to the formation of 3D networks for hydrogel (Fig. 2B).
BSA, a widely studied protein, has been used as a model protein for diverse biophysical, biochemical, and 
physicochemical studies29–31. The unique 3D structure of BSA, determined by X-ray crystallography, is composed 
of three domains (I, II, and III) that confer a heart-shaped molecular structure; the structure forms a large hydro-
phobic cavity that acts as a hydrophobic binding site32,33. BSA’s ability to bind to a variety of hydrophobic ligands, 
such as fatty acids34, bilirubin35, warfarin36, tryptophan37, and several dyes, has been reported. For this study, the 
turning function of GSII in the peptide backbone of h9e played a key role in hydrogel formation by interacting 
with hydrophobic force15, and the added BSA enhanced the hydrophobic interaction by acting as a linker that 
binds multiple sequences of GSII through hydrophobic force.
Oscillatory rheology. Oscillatory rheology measurements were performed to observe gelation kinetics of 
0.25, 0.5, and 1.0 wt% h9e hydrogels at 37 °C (Fig. 3A and B). In order to study the effects of temperature on gel 
formation, we treated 0.5 wt% h9e hydrogels at various temperatures (37, 30, and 22 °C) (Fig. 3C). Measurements 
Figure 1. Fluorescence spectra from camptothecin encapsulated in h9e hydrogel.  Insert shows the enlarged 
square area.
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were carried out immediately after h9e hydrogel was mixed with the trigger solution. G′ for 0.25, 0.5, and 1.0 wt% 
H9e hydrogel at 37 °C were 35, 432, and 2480 Pa, while for G′′, the values are 7, 53, and 220, respectively, 60 min-
utes after initial gel formation. For the 0.5% h9e hydrogel at various temperatures, G′ increased more quickly at 
a higher temperature than at a lower temperature. In another group, results of a sample encapsulated with camp-
tothecin indicated that this small hydrophobic drug did not obviously change the strength of h9e hydrogel (data 
not shown).
The influence of camptothecin on strength and gelation recovery after shear-thinning treatment (Fig. 4) was 
also evaluated. Freshly prepared 0.5% h9e hydrogel with and without 2.5 mM camptothecin was kept in the plate 
at 37 °C for 60 minutes. Steady shear (100 s−1 for 10 s) was subsequently applied to the samples to mimic shear 
forces applied to the samples in a syringe injection process. For the sample without camptothecin, observed mod-
uli were 86 Pa immediately after the shear-thinning treatment and 160 Pa 60 minutes after shear-thinning. For 
the sample loaded with 2.5 mM camptothecin, observed moduli were 63 Pa immediately after shear thinning and 
150 Pa 60 minutes after shear-thinning. Essentially, no significant effect of camptothecin was found on gelation, 
shear-thinning, or the gel recovery process. In another work, we have done the shear-thinning treatment with 
trigger calcium and observed the moduli recovery over 2 hours, and similarly, only minor effect of camptothecin 
on the shear-thinning properties of H9e hydrogel was found (data not shown).
Results reported in this study are in agreement with results reported by Huang et al.15 H9e hydrogel with and 
without camptothecin immediately displayed solid-like properties after shear thinning and recovered within a 
short time period.
Camptothecin diffusion. The most common methods currently used to study drug diffusion in gel matrices 
are sample separation and dialysis38. In this study, we introduced the drug-loaded h9e hydrogel into a dialysis tube 
in a flask containing Phosphate-buffered saline (PBS) buffer as the outer solution. We monitored the drug release 
for a specified time by measuring UV absorbance of the camptothecin diffused into the flask; representative data 
for 0.5 wt% H9e hydrogel in 37 °C are plotted in Fig. 5. Diffusion studies with the dialyzer showed that approxi-
mately 80% of the camptothecin diffused from the dialyzer into the outer solution within 5 hours at 37 °C (Fig. 6); 
the rates of camptothecin release from peptide hydrogel concentrations of 0.25, 0.5, and 1% were comparable, 
suggesting that the passage of camptothecin through the dialyzer° occurs independently of H9e hydrogel concen-
tration and that peptide binding is not a concern in camptothecin diffusion.
HeLa cell viability. The ability of camptothecin to induce apoptosis in HeLa cells by microRNA-125b- 
mediated mitochondrial pathways has been previously reported39. After treating Hela cells in h9e hydrogel for 3 
days with various concentrations of camptothecin, we found a dose-dependent decrease in cell proliferation indi-
cated by the absorbance of 450 nm obtained from CCK-8 assay (Fig. 7) and cell viability (Fig. 8). The final DMSO 
in the 2D cell culture and 3D h9e hydrogel was 0.34 (w/v)%; previously it has been reported that when the con-
centration of DMSO in the cell culture was below 0.5%, no obvious cytotoxicity was observed in Hela cells40, and 
because we have added an equal concentration of DMSO in all samples, the impact of DMSO on the differences 
of result can be ignored. Various concentrations of h9e hydrogel treated with the same amount of camptothecin 
showed comparable cell viability, implying that h9e hydrogel didnot inhibit the effects of camptothecin for killing 
HeLa cells. This result was in accordance with our fluorescence measurement and diffusion results, which demon-
strated that h9e hydrogel did not inhibit the diffusion of camptothecin. In addition, 2D and 3D cultures promoted 
Hela cell proliferation over time; however, the proliferation rate indicated was higher for 2D culture than for 3D 
culture samples (Fig. 7). Similar phenomena were also found in other 3D culture systems41 and other tumor cells 
Figure 2. Tapping mode AFM height images of H9e hydrogelin 100 mM sodium bicarbonate solution (A) and 
100 mM sodium bicarbonate solution containing PGworks (B).
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in H9e hydrogel14. Because the increase of h9e hydrogel concentration didnot lead to decreased cell viability, we 
suggest that the proliferation difference for samples in 2D and 3D cultures was caused by growth pattern change.
Conclusions
H9e hydrogel showed a negligible binding effect with the hydrophobic drug camptothecin used in this study 
as a model for small hydrophobic drugs. Therefore, gel strength and recovery properties of h9e hydrogel were 
not significantly influenced by the addition of camptothecin, and the camptothecin molecule diffused well in 
h9e hydrogel. In vitro experiments with HeLa cells have shown that camptothecin induced dose-dependent cell 
viability, and the increase in hydrogel concentration did not significantly impact the drug efficacy test, suggesting 
that h9e hydrogel did not influence biological activities of cells induced by camptothecin. The combined physical 
and biological results clearly indicate that h9e hydrogel is an appropriate 3D cell culture matrix to test the effect 
of camptothcin. Our research team is exploring the performance of h9e hydrogel with protein drugs, hydrophilic 
drugs with large molecular weight, BSA-linked drugs, and other hydrophobic drugs.
Figure 3. Storage (G′) and loss (G′′) moduli of 0.25, 0.5, and 1 wt% H9e hydrogel in DMEM containing 10% FBS 
during hydrogelation at 37 °C (A,B) respectively)), and G′ of 0.5 wt% at 22, 30, and 37 °C (C).
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Figure 4. Storage modulus (G′) recovery at 37 °C after shear–thinning treatment for 0.5 wt% H9e hydrogel 
prepared in DMEM containing 5% H9e hydrogel without (A) and with (B) 2.5 mM camptothecin.
Figure 5. Absorbance spectra of the surrounding solution in the release experiment of camptothecin from 
H9e hydrogel. Measurements were taken at 0.5-h intervals initially and then later increased to 13 h. Lowest and 
highest curves were obtained at 0.5 and 21 h, respectively.
Figure 6. Fraction release of camptothecin as a function of time from various concentrations of H9e 
hydrogel at 37 °C. 
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Materials and Methods
Hydrogel preparation. H9e hydrogel kit (PepGel PGmatrix) at a concentration of 2 wt% H9e hydrogel pep-
tide solution and PGworks solution were provided by Dr. Sun’s lab in the Department of Grain Science, Kansas 
State University. For hydrogelation, H9e hydrogel solution, was added into 100 mM sodium bicarbonate solution, 
or Dulbecco Minimum Essential Medium (DMEM, Sigma Chemical, St. Louis, MO) containing 5% PGworks 
protein based solution, or DMEM containing 10% Fetal Borne Serum (FBS); both are used to trigger the hydrogel 
formation. The hydrogel formed within 30 minutes at room temperature with a final peptide concentration of 
0.25, 0.5, or 1 wt%, respectively.
Fluorescence. The fluorescence technique was used to evaluate the interactions between camptothecin and 
hydrogel peptide nanofibers, using a PAM-101–103 fluorometer (H. Walz, Germany). Emission spectra ranged 
from 400 to 650 nm with an excitation wavelength of 370 nm. To minimize background scattering, the h9e 
hydrogel peptide was dissolved in 100 mM sodium bicarbonate. Camptothecin was dissolved into dimethyl sul-
phoxide (DMSO) to prepare 50 mM of stock solution, and aliquots of the drug stock solution were added to the 
hydrogel-forming solution to obtain a final concentration of 2.5 mM for camptothecin and 5% (v/v) for DMSO. 
Final camptothecin concentrations for this experiment were 2.5 mM in 0.25, 0.5, and 1 wt % h9e hydrogel, respec-
tively. The mixture solutions were kept in the fluorescence cells for 30 minites before measurements were carried 
out. For the control, 2.5 μ M camptothecin in 100 mM sodium bicarbonate solution containing 5% (v/v) dimethyl 
sulfoxide (DMSO) without h9e hydrogel was used to determine spectroscopic characteristics of camptothecin in 
aqueous solution. Spectra were normalized at the emission peak.
Figure 7. Effect of camptothecin on the absorbance of 450 nm obtained from CCK-8 assay. Error bars are 
+/− standard error (n = 3). The p-value of each group samples against another two groups with different 
camptothecin concentration was under 0.0001, while in the same group, p-value of each sample against another 
two samples with different h9e hydrogel concentration was above 0.50.
Figure 8. Viability of HeLa cells treated with 3.125 uM, 6.25 uM, and 12.5 uM camptothecin in 0.25, 0.5, 
and 1 wt% hydrogels for 3 days. Error bars are + /− standard error (n = 3). The p-value of each group samples 
against another two groups with different camptothecin concentration was under 0.0001, while in the same 
group, p-value of each sample against another two samples with different h9e hydrogel concentration was above 
0.50.
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Atomic force microscopy. Tapping mode AFM images were collected using an Innova Atomic Force 
Microscope (Bruker, Camarillo, CA) under ambient conditions. The 2 wt% h9e hydrogel solution was diluted 
with DI water to a final concentration of 0.004 wt%. Samples were prepared by spotting 20 μ l solution with and 
without PGworks solution on 12-mm mica discs that were then settled at room temperature for at least 3 hours 
until the solution dried completely. Drive frequency of the silicon tip was tuned and fixed at 200–250 kHz before 
engagement. Amplitude profiles were obtained using Nanoscope Analysis software V1.40. All collected images 
were flattened before further analysis.
Rheological tests. Gelation of the h9e hydrogel as function of time was determined by using the C-VOR 150 
rheometer system (Malvern Instruments, Malvern, Worcestershire, United Kingdom) with a 20-mm-diameter 
parallel plate geometry and 500-mm gap size. Storage moduli (G′) was used as the gel strength. Samples with 
and without camptothecin were prepared as previously described with DMEM containing 5% PGworks solution. 
Immediately after the PGworks solution was added, 200 μ l of gel-forming solution was placed on the measuring 
system. A single frequency (1 Hz) and a steady shear strain (1%) were used for the test. For shear-thinning exper-
iments, samples were subjected to 100 s−1 shear for 10 seconds, after which the strain was reduced to 1%. Gel 
recovery of G′ as a function of time (1 Hz frequency, 1% strain) was subsequently monitored for 1 hour.
Camptothecin diffusion test. Drug diffusion was observed by measuring the drug released from the gel to 
the outer solution. Aliquots of the drug in DMSO were added to the hydrogel-forming solution to obtain a final 
concentration of 2.5 mM for camptothecin and 5% (v/v) for DMSO. Samples containing 0-mM camptothecin 
were prepared using DMSO without camptothecin. A Float-a-Lyzer (1000 KD MWCO, 1-mL capacity, regener-
ated cellulose membrane) was purchased from Spectrum Labs (Rancho Dominguez, CA). We used the 1000 KD 
MWCO membrane because the MWCO’s aperture is large enough to allow the h9e hydrogel peptide and camp-
tothecin molecules to pass through. Then 1 mL of 0.25, 0.5, and 1 wt% hydrogel containing 2.5 mM camptothecin 
in 100 mM sodium bicarbonate was introduced into the inner tube of the dialyzer, which was then placed into 
a 500-mL glass cylinder containing 300 ml phosphate-buffered saline (PBS) as release media (outer solution). 
The outer solution was continually stirred at 130 rpm using a small magnetic stir bar to prevent formation of an 
unstirred water layer at the membrane/outer solution interface. Sampling the contents of the outer solution at 
periodic intervals assessed drug diffusion to the outer solution at 37 °C. At certain time intervals, 1 ml of solution 
was taken from each release system (i.e., the outer solution ) for UV absorbance measurements, and the same 
volume of a PBS buffer, previously kept at 37 °C temperature as the individual release system, was added in order 
to maintain a constant volume of outer solution.
UV absorbance measurements were carried out on a UV-1650PC spectrophotometer (Shimadzu, Kyoto, 
Japan). The absorbance peak at 370 nm was recorded for all measured solutions. A release fraction was calculated 
by the function (It/I∞), where It is the absorbance of drug released at time t, and I∞ is the absorbance of drug 
released at time infinite; the latter marks the measured absorbance of total camptothecin in the 1 ml h9e hydrogel 
dissolved in 300 ml PBS. Released fractions were averaged from three replicates for each sample, and mean values 
and standard errors were determined each time.
Cell culture and drug efficacy tests. HeLa cell suspension in DMEM media was prepared following com-
monly used methods. Cells were detached from 2D cell culture flask by using a trypsin treatment and cell pellet 
was collected by centrifugation at 1000 rpm for 5 minutes, and re-suspended in DMEM. Cell concentration was 
counted using an Auto Cellometer Mini (Nexcelom Bioscience, Lawrence, MA). Aliquots of HeLa cells solution 
were then added into H9e hydrogel DMEM containing 10% FBS with a final peptide concentration of 0, 0.25, 0.5, 
and 1 wt%. Then 100 μ l of cell mixture solution (3 × 104 cells /wall) was seeded into a 96-wall culture plate (Becton 
Dickinson Labware, Franklin Lakes, NJ) and placed in an incubator (Nuair, Playmouth, MN) in a humidified 
5% CO2 atmosphere at 37 °C for approximately 30 minutes. After gelation, 10 μ l of DMEM with 5% (v/v) DMSO 
containing 0, 50 uM, 100 uM, and 200 uM camptothecin was added on top of the hydrogel in order to obtain 
camptothecin concentrations of 0 μ M, 3.125 μ M, 6.25 μ M, and 12.5 μ M, respectively. Then 50 μ l of DMEM was 
carefully added to the top of the hydrogel to prevent the gel from drying. All measurements were made at least in 
triplicates, and the plates were incubated for 3 days.
A CCK-8 assay was used to determine cell viability after each treatment, and 10 μ L of CCK solution was added 
to each wall. After 4 hours of incubation, absorbance at 450 nm was collected on a microplate reader (mQuant, 
Bio-Tek) and corrected by subtracting the background signal from a wall containing only 160 μ l DMEM with 10% 
FBS. Absorption intensities were averaged from three replicates for each sample and normalized by cells seeded in 
H9e hydrogel cell culture without being treated with camptothecin (control) in order to obtain cell viability. Mean 
values and standard errors were determined each time. For group comparisons, the one-way layout ANOVA with 
duplication was applied. Significant differences in the mean values were evaluated by the student’s unpaired t-test. 
A p value of less than 0.05 was considered significant.
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